Fact CheckerSign in

NCT07376187Not yet recruiting

Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases

Digital Physiotherapy Services in the Management of Pediatric Chronic Suppurative Lung Diseases: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 30 Jan 2026

Brief summary (registry, in English)

This is a prospective, single-center, two-arm (1:1), assessor-blinded, randomized controlled clinical trial that will be conducted in collaboration with the outpatient clinic of the third Pediatric Pulmonology Unit, "Attikon" University Hospital of Athens in Greece. The aim of the study is to investigate the effects of applying digital physiotherapy services in the management of specific clinical outcomes in children with chronic suppurative lung diseases, other than cystic fibrosis. The research question is whether airway clearance techniques and exercise training that are performed remotely using digital health services (DHSs) can improve functional and exercise capacity, as well as compliance with ACTs, compared to usual care. The intervention program includes airway clearance techniques (ACTs), as well as aerobic and strengthening exercises that can be implemented easily in an online setting at home with minimal equipment. The duration of the program will be 12 weeks, and the prescribed weekly regimen will consist of 50-minute remote sessions: two synchronous, supervised sessions conducted via the Vsee platform, and a minimum of one asynchronous, unsupervised session. Children will be encouraged to maintain daily adherence to the exercise protocol.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
32 (estimated)
First submitted
21 Jan 2026
Start date
1 May 2026
Primary completion date
31 Dec 2027
Lead sponsor
University of Thessaly
NCT number
NCT07376187

What you commit to

  • Study type: Interventional
  • Planned participants: 32
  • From 1 May 2026 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Immunodeficiency or asthma as their primary condition
  • Clinical evidence of cardiovascular, neuromuscular, metastatic, or psychiatric comorbidities, and neuromuscular or musculoskeletal impairments that affect mobility and the ability to follow instructions
  • Medical history of lung transplant

Other

  • Cystic fibrosis
  • Participation in other rehabilitation programs, or attendance at regular physiotherapy ACTs sessions (\>10 sessions in a 3-month period)
  • Lack access to the internet (e.g., no smartphone, tablet, or laptop)
  • Inability to use technological devices

Who the study is looking for

  • children aged 6 to 12 years old
  • clinically stable with an absence of pulmonary exacerbation four weeks prior to the study's recruitment
  • adherence to attend regular medical follow-up from a pediatric pulmonologist every three months

Age in the registry: 6 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Physiotherapy Department, University of Thessaly
Coordinator of this site? Confirm its status
LamiaGreeceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.